Actively Recruiting
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
Led by Kettering Health Network · Updated on 2026-04-08
64
Participants Needed
2
Research Sites
463 weeks
Total Duration
On this page
Sponsors
K
Kettering Health Network
Lead Sponsor
A
American Society for Surgery of the Hand
Collaborating Sponsor
AI-Summary
What this Trial Is About
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
CONDITIONS
Official Title
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with carpal tunnel syndrome by physical exam or EMG
- Age over 18 years
You will not qualify if you...
- Allergy to bupivacaine
- Use of opioids within the last six months before surgery
- Allergy to Percocet or acetaminophen
- Taking tricyclic antidepressants
- Being a prisoner or pregnant woman
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Orthopedic Associates of Southwest Ohio
Dayton, Ohio, United States, 45414
Actively Recruiting
2
Orthopedic Associates of Southwest Ohio
Dayton, Ohio, United States, 45459
Actively Recruiting
Research Team
R
Ronald Buczek, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here